What are the recommendations for a patient with a Body Mass Index (BMI) less than 22 who is taking Glucagon-Like Peptide-1 (GLP-1) receptor agonists, such as semaglutide (GLP-1 receptor agonist) or tirzepatide (GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist), for weight loss?
Theres no direct link between muscle loss and cramping, but you should still strive to preserve as much muscle as possible while on a GLP-1
VISIA imaging may be used to track soft tissue changes or monitor skin quality over time
Their benefits are greatest when combined with: Nutrition : A balanced, protein-rich, whole-food diet Exercise : Both resistance training and cardio improve outcomes Supplements and peptides : Options like Omega 1300, MOTS-c, and Tesamorelin may complement GLP-1 therapy Lifestyle : Stress reduction, sleep optimization, and ongoing medical monitoring This integrated approach ensures patients not only lose weight, but also protect their long-term health
Jumping to a higher dose too quickly, or accidentally injecting 100 units from a concentrated vial, triggers severe gastrointestinal side effects that the semaglutide fatigue and nausea response can make genuinely debilitating